enteroviru
nonenvelop
positivesens
singl
strand
rna
viru
belong
famili
picornavirida
one
major
pathogen
caus
hand
foot
mouth
diseas
young
children
especi
year
transmit
person
person
direct
contact
saliva
nasal
mucu
stool
blister
infect
infect
mild
selflimit
infect
individu
slight
fever
herpangina
rash
mouth
hand
bodi
sever
case
may
progress
develop
asept
mening
enceph
poliolik
symptom
central
nervou
system
cn
infect
result
pulmonari
edema
pulmonari
hemorrhag
lung
may
fatal
patient
survivor
sever
infect
may
irrevers
neural
three
larg
outbreak
record
recent
decad
individu
infect
fatal
case
report
caus
death
victim
antivir
drug
avail
treat
infect
develop
specif
drug
may
improv
clinic
outcom
infect
patient
rna
genom
encod
larg
precursor
polypeptid
process
viral
proteas
gener
viral
structur
protein
nonstructur
protein
viral
attach
receptor
viru
endocytos
via
clathrinco
vesicl
uncoat
releas
genom
rna
unlik
cellular
messag
rna
viral
genom
rna
lack
cap
structur
end
recruit
ribosom
initi
protein
translat
highli
structur
untransl
region
utr
contain
intern
ribosom
entri
site
ire
interact
ire
transact
factor
itaf
facilit
initi
heterogen
nuclear
ribonucleoprotein
hnrnp
one
member
itaf
involv
synthesi
viral
genom
infect
induc
reloc
hnrnp
nucleu
cytoplasm
may
benefici
viral
viral
proteas
hydrolyz
eukaryot
initi
factor
poli
bind
protein
pabp
essenti
capdepend
hydrolyt
reaction
caus
switch
capdepend
translat
iresdepend
translat
hijack
host
translat
machineri
synthes
viral
accumul
evid
indic
redox
state
host
may
play
import
role
viral
pathogenesi
suscept
virus
dengu
viru
enteroviru
coronaviru
relat
redox
state
host
antioxid
known
deter
viral
infect
instanc
glutathion
resveratrol
inhibit
influenza
infect
cell
anim
treatment
synthet
antioxid
mitotempo
nacetylcystein
natur
antioxid
epigallocatechin
gallat
egcg
gallocatechin
gallat
gcg
diminish
antivir
capac
tea
polyphenol
correl
antioxid
abil
studi
suggest
redox
state
host
import
determin
viral
suscept
antioxid
capac
herbal
extract
partli
account
antivir
activ
schizonepeta
tenuifolia
briq
st
also
call
jing
jie
china
annual
plant
belong
famili
labiata
east
asia
fresh
stem
leaf
st
usual
use
ingredi
sever
food
recip
herbal
tea
benefici
drink
medicin
cuisin
herbal
spike
stem
leav
st
sundri
carbon
use
medicin
st
contain
number
bioactiv
constitu
supplementari
tabl
st
use
treat
common
cold
headach
fever
allerg
dermat
skin
rash
inflammatori
antivir
activ
associ
st
st
use
formul
yinqiaodecoct
prove
effect
reduct
hemagglutinin
titer
viru
lung
tissu
influenza
virusinfect
howev
previou
report
antienterovir
activ
st
extract
controversi
hsu
et
al
show
ethanol
extract
st
inhibit
one
four
clinic
isol
screen
activ
taiwanes
folk
medicin
plant
contrast
lin
et
al
show
aqueou
extract
dri
st
activ
among
antipyret
toxinelimin
tradit
chines
present
studi
demonstr
activ
ste
ste
inhibit
cytopath
effect
plaqu
format
genom
rna
replic
moreov
allevi
symptom
enhanc
surviv
mice
mechanist
ste
inhibit
ro
gener
hnrnp
transloc
cleavag
eukaryot
translat
initi
factor
kinasemedi
ep
phosphoryl
find
suggest
ste
exert
antivir
activ
action
number
target
use
modifi
plaqu
assay
screen
antienterovir
activ
herbal
extract
rd
cell
infect
pfu
differ
strain
brcr
overlaid
agaros
contain
ste
ste
significantli
reduc
plaqu
format
brcr
strain
complet
abrog
plaqu
format
strain
rd
fig
vero
cell
supplementari
fig
concentr
ste
cytotox
effect
rd
cell
supplementari
fig
vero
cell
supplementari
fig
valid
antivir
effect
ste
infect
rd
cell
brcr
strain
quantifi
level
genom
rna
level
rna
decreas
nearli
upon
treatment
ste
respect
fig
parallel
dosedepend
decreas
express
protein
includ
viral
rna
depend
rna
polymeras
viral
proteas
express
level
lower
infect
cell
presenc
ste
likewis
express
level
decreas
infect
cell
treat
ste
fig
reduct
level
genom
rna
protein
accompani
signific
decreas
progeni
viru
amount
intracellular
extracellular
viral
particl
decreas
order
magnitud
stetreat
infect
cell
compar
control
treatment
group
fig
find
demonstr
ste
possess
activ
studi
mechan
antivir
activ
ste
perform
timeofaddit
assay
studi
stage
ste
inhibit
infect
ste
ad
differ
period
brcr
infect
fig
immunoblot
conduct
express
indic
viral
replic
shown
fig
treatment
ste
prior
adsorpt
condit
fail
suppress
replic
even
slightli
promot
ste
treatment
cell
viral
adsorpt
period
condit
moder
diminish
replic
addit
ste
viral
adsorpt
period
significantli
suppress
replic
condit
ste
present
viraladsorpt
postadsorpt
period
condit
replic
sever
repress
find
suggest
ste
inhibit
viral
viraladsorpt
postadsorpt
phase
appar
synergi
antivir
activ
act
phase
antivir
activ
ste
act
viral
adsorpt
period
impli
ste
may
interact
virion
make
unavail
attach
surfac
receptor
test
possibl
mix
viru
ste
water
remov
excess
ste
use
centrifug
filtrat
determin
titer
infecti
viru
titer
infecti
viru
ste
treatment
group
pfuml
significantli
lower
water
treatment
group
pfuml
fig
find
suggest
ste
may
interact
virion
interfer
subsequ
attach
cellular
receptor
ste
antivir
activ
postvir
adsorpt
phase
switch
capdepend
iresdepend
translat
occur
cours
studi
whether
ste
affect
process
transfect
cell
bicistron
report
fig
infect
transfect
cell
hour
subsequ
treat
ste
firefli
luciferas
activityrenilla
luciferas
activ
flucrluc
ratio
cell
increas
compar
uninfect
cell
p
ste
treatment
postadsorpt
phase
effect
inhibit
increas
fig
ratio
firefli
renilla
luciferas
activ
indic
rel
preponder
ire
capdepend
translat
find
suggest
ste
may
abolish
switch
cap
iresdepend
translat
valid
whether
ste
treatment
prevent
termin
host
translat
examin
level
translat
initi
factor
target
enterovir
proteas
rd
cell
infect
treat
ste
condit
depict
fig
infect
caus
complet
cleavag
condit
pretreat
ste
prior
viral
adsorpt
condit
affect
process
presenc
ste
viral
adsorpt
phase
partial
block
cleavag
condit
addit
ste
cell
postadsorpt
significantli
deter
cleavag
condit
inclus
ste
adsorpt
postadsorpt
phase
synergist
inhibit
degrad
condit
find
suggest
ste
prevent
shutdown
capdepend
translat
mainten
activ
plausibl
ste
interfer
iresdepend
translat
known
transact
factor
hnrnp
reloc
cytoplasm
interact
utr
facilit
explor
possibl
studi
whether
ste
treatment
affect
reloc
hnrnp
infect
cell
transfect
rd
cell
express
vector
encod
gfptag
hnrnp
infect
transfect
cell
brcr
studi
effect
ste
treatment
shown
fig
gfptag
hnrnp
local
nuclei
mocktransfect
cell
infect
caus
reloc
hnrnp
nucleu
cytoplasm
treatment
infect
transfect
ste
inhibit
chang
hnrnp
distribut
high
throughput
imag
appli
quantifi
percentag
cell
show
cytoplasm
reloc
gfptag
hnrnp
percentag
cell
mockinfect
cell
significantli
increas
cell
ste
treatment
caus
signific
reduct
cytoplasm
gfpposit
cell
percentag
cytoplasm
gfpposit
infect
cell
drop
upon
treatment
ste
fig
find
suggest
ste
may
suppress
iresdepend
translat
inhibit
hnrnp
reloc
kinas
known
regul
hnrnp
possibl
ste
neg
regul
hnrnp
transloc
modul
signal
test
possibl
infect
rd
cell
brcr
strain
treat
infect
cell
without
ste
harvest
immunoblot
phosphoryl
kinas
erk
infect
appear
caus
biphas
activ
kinas
modest
increas
kinas
phosphoryl
around
min
p
second
phase
stronger
phosphoryl
occur
h
p
intens
kinas
phosphoryl
steadili
increas
h
p
fig
ste
treatment
significantli
inhibit
phase
kinas
phosphoryl
fig
contrari
infect
induc
phosphoryl
erk
h
viral
adsorpt
ste
treatment
significantli
alter
kinet
erk
phosphoryl
essenti
role
kinas
activ
infect
demonstr
inhibitori
effect
kinas
inhibitor
express
fig
middl
panel
level
cell
reduc
dosedepend
manner
moreov
product
progeni
viru
suppress
level
intracellular
extracellular
progeni
viru
produc
cell
treat
lower
dmsotreat
cell
fig
find
suggest
infect
specif
activ
kinas
ste
suppress
kinas
activ
intriguingli
treatment
rescu
cleavag
fig
middl
panel
impli
cleavag
independ
kinas
activ
studi
possibl
kinas
pathway
mediat
cytoplasm
reloc
hnrnp
examin
effect
hnrnp
distribut
infect
cell
shown
fig
percentag
cytoplasm
reloc
hnrnp
brcrinfect
cell
decreas
dosedepend
manner
find
suggest
activ
cytoplasm
hnrnp
transloc
via
kinas
pathway
known
hydrogen
peroxid
induc
kinas
infect
associ
increas
oxid
rais
possibl
may
activ
kinas
ro
signal
ste
may
inhibit
ro
signal
studi
hypothesi
first
examin
antioxid
activ
ste
antioxid
capac
ste
quantifi
use
ferric
reduc
antioxid
power
frap
assay
mg
trolox
equival
per
gram
lyophil
ste
studi
antioxid
role
ste
curb
infectionassoci
ro
gener
stain
cell
fluoresc
probe
cellrox
deep
red
reagent
determin
ro
gener
cell
elev
ro
level
detect
brcr
cell
compar
mockinfect
cell
fig
supplementari
fig
howev
ste
caus
signific
reduct
ro
gener
proceed
studi
whether
ste
affect
activ
kinas
treat
rd
cell
examin
effect
ste
phosphoryl
kinas
hydrogen
peroxid
treatment
caus
dosedepend
increas
kinas
phosphoryl
rd
cell
fig
lane
treatment
ste
significantli
reduc
basal
level
lane
vs
lane
increas
lane
vs
lane
phosphoryl
find
suggest
rosinduc
kinas
activ
inhibit
ste
anoth
target
protein
kinas
implic
membran
may
play
import
role
rna
synthesi
viru
infect
rd
cell
induc
phosphoryl
fig
lane
vs
treatment
cell
ste
significantli
reduc
phosphoryl
fig
lane
valid
whether
kinas
pathway
mediat
phosphoryl
studi
effect
kinas
inhibitor
phosphoryl
cell
phosphoryl
cell
reduc
presenc
fig
find
suggest
kinas
involv
phosphoryl
probabl
ste
inhibit
phosphoryl
via
suppress
effect
kinas
studi
ste
treatment
protect
mice
infect
infect
mice
treat
ste
mgkg
examin
surviv
clinic
sign
surviv
rate
stetreat
infect
mice
n
significantli
higher
watertr
infect
mice
n
fig
stetreat
infect
mice
display
milder
symptom
rehabilit
quickli
watertr
counterpart
higher
percentag
infect
mice
water
treatment
group
show
paralysi
one
limb
ste
treatment
group
fig
c
addit
sever
paralyz
mice
water
treatment
group
recov
ill
find
suggest
ste
offer
protect
infect
vivo
present
studi
shown
ste
offer
protect
vitro
vivo
mechanist
exert
antivir
activ
via
number
differ
mechan
interfer
viral
attach
host
cell
suppress
cleavag
hinder
cytoplasm
transloc
hnrnp
cytoplasm
reloc
hnrnp
involv
ro
signal
kinas
activ
ste
act
scaveng
ro
inhibit
kinas
phosphoryl
addit
anoth
target
molecul
kinas
phosphoryl
cell
phosphoryl
inhibit
ste
find
suggest
ste
exert
power
antivir
activ
effect
drug
avail
treatment
patient
controversi
result
antivir
effect
ste
use
modifi
plaqu
assay
screen
herbal
extract
activ
found
ste
offer
protect
brcr
strain
ste
inhibit
cpe
reduc
level
genom
rna
plaqu
form
progeni
viru
differ
report
vitro
antivir
activ
ste
may
attribut
differ
method
extract
hsu
et
al
use
combin
organ
solvent
lin
et
al
use
boil
water
differ
extract
method
may
affect
natur
amount
pharmacolog
activ
constitu
addit
ste
allevi
clinic
symptom
enhanc
surviv
mice
find
indic
ste
antivir
activ
vitro
vivo
mechanist
step
ste
inhibit
infect
determin
use
timeofaddit
assay
ste
act
viral
adsorpt
postadsorpt
stage
treatment
viru
ste
reduc
amount
infecti
viru
fig
appar
ste
directli
interact
virion
make
unavail
infect
probabl
constitu
ste
bind
virion
interfer
attach
virion
receptor
known
triterpenoid
glycyrrhiza
uralensi
ganoderma
lucidum
block
adsorpt
uncoat
though
triterpenoid
major
constitu
schizonepeta
tenuifolia
briq
possibl
natur
compound
present
ste
may
act
similar
manner
altern
ste
may
directli
inactiv
virion
number
mechan
account
abil
ste
inhibit
infect
postadsorpt
stage
ste
block
suppress
host
cell
translat
switch
viral
translat
viral
proteas
cleav
necessari
translat
host
cell
mrna
possibl
ste
directli
inhibit
proteas
rosmarin
acid
one
bioactiv
constitu
known
inhibit
cystein
anoth
possibl
exclus
explan
ste
reduc
translat
viral
rna
thu
level
proteas
initi
viral
rna
translat
entail
bind
itaf
host
initi
factor
type
ire
element
one
member
itaf
hnrnp
interact
stem
loop
ii
ire
requir
enterovir
translat
infect
induc
transloc
hnrnp
nucleu
cytoplasm
fig
stimul
ire
similar
observ
made
poliovirusinfect
abil
ste
suppress
cytoplasm
reloc
hnrnp
may
account
reduc
enterovir
translat
replic
besid
apigenin
shown
prevent
interact
rna
hnrnp
glycosid
deriv
apigenin
also
constitu
current
clear
glycosid
deriv
function
way
apigenin
shuttl
hnrnp
cytoplasm
nucleu
regul
ro
arsenit
treatment
induc
oxid
stress
caus
cytoplasm
reloc
hnrnp
also
found
hydrogen
peroxid
treatment
rd
cell
result
transloc
hnrnp
nucleu
cytoplasm
supplementari
fig
shown
infect
caus
mitochondri
dysfunct
nadph
oxidas
result
ro
gener
increas
ro
may
elicit
subsequ
signal
hnrnp
reloc
ste
may
act
ro
scaveng
block
hnrnp
transloc
consist
notion
ste
display
strong
antioxid
moreov
ste
significantli
reduc
ro
gener
cell
fig
supplementari
fig
possibl
ro
scaveng
ste
diminish
hnrnp
transloc
signal
may
involv
particip
mapkrel
pathway
activ
kinas
promot
inhibit
kinas
suppress
enterovir
translat
fig
like
kinas
play
import
role
infect
consist
kinas
signal
cascad
involv
regul
subcellular
distribut
hnrnp
activ
kinas
suffici
promot
reloc
hnrnp
pharmacolog
inhibit
kinas
block
transloc
process
fig
shown
ste
inhibit
activ
kinas
fig
mechan
underli
action
ste
remain
elus
known
ro
activ
hydrogen
peroxid
treatment
caus
kinas
phosphoryl
suppress
presenc
ste
fig
antioxid
treatment
inhibit
kinas
possibl
ste
scaveng
ro
reduc
activ
kinas
addit
ste
may
affect
express
enzym
involv
redox
metabol
instanc
ste
downregul
express
induc
nitric
oxid
oral
administr
ste
induc
hepat
express
catalas
superoxid
dismutas
glutathion
peroxidas
mous
model
find
suggest
ste
may
suppress
activ
kinas
hnrnp
reloc
via
antioxid
mechan
anoth
target
kinas
appear
play
import
role
infect
identifi
independ
phosphoryl
protein
egfr
complex
egfstimul
bind
protein
oncogen
variant
confoc
microscop
studi
reveal
coloc
clathrin
clathrinco
silenc
express
reduc
endocytosi
egfr
transferrin
find
impli
involv
ligandinduc
recent
find
suggest
phosphoryl
modul
biochem
phosphoryl
requir
ligandinduc
phosphoryl
kinas
locat
phosphoryl
site
impli
function
role
endocyt
reveal
play
essenti
role
infect
knockdown
significantli
reduc
extent
enterovir
result
interpret
essenti
endocytosi
infecti
entri
process
may
implic
membran
traffick
essenti
replic
found
robust
increas
phosphoryl
kinas
mid
late
phase
life
cycl
fig
suggest
role
replic
agreement
enteroviru
exploit
endocyt
machineri
transfer
cholesterol
plasma
membran
cultur
medium
replic
organel
cholesterol
facilit
rna
replic
antivir
activ
ste
may
least
part
account
abil
inhibit
kinas
phosphoryl
base
find
propos
model
antivir
activ
ste
supplementari
fig
scheme
ste
act
number
way
deter
viral
infect
ste
bind
virion
suppress
adsorpt
intern
inhibit
cleavag
scaveng
ro
suppress
kinas
activ
quell
cytoplasm
reloc
hnrnp
posttransl
modif
ste
contain
variou
bioactiv
constitu
may
specif
antivir
activ
mention
unless
otherwis
state
chemic
purchas
sigmaaldrich
st
loui
mo
usa
dulbecco
modifi
eagl
medium
dmem
modifi
eagl
medium
mem
fetal
bovin
serum
fb
antibiot
trypsinedta
nonessenti
amino
acid
neaa
glutamin
trypan
blue
acquir
thermo
fisher
scientif
inc
waltham
usa
fluorogen
dye
cellrox
deep
red
reagent
diacet
purchas
thermo
fisher
scientif
inc
waltham
usa
african
green
monkey
kidney
epitheli
cell
vero
atcc
cultur
mem
heatinactiv
fb
uml
penicillin
mgml
streptomycin
amphotericin
human
rhabdomyosarcoma
cell
rd
atcc
maintain
dmem
supplement
fb
unitsml
penicillin
mgml
streptomycin
amphotericin
mm
lglutamin
mm
neaa
cell
cultur
humidifi
environ
three
clinic
isol
strain
use
studi
prototyp
strain
brcr
belong
genogroup
clinic
isol
belong
genogroup
classifi
genogroup
viru
stock
propag
vero
rd
cell
previous
mous
adapt
strain
produc
infecti
clone
infecti
clone
plasmid
linear
mlui
vitro
transcript
perform
use
megascript
transcript
kit
thermo
fisher
scientif
waltham
usa
rd
cell
set
plate
per
well
incub
overnight
three
microgram
viral
rna
transfect
rd
cell
use
lipofectamin
thermo
fisher
scientif
waltham
usa
accord
manufactur
instruct
h
incub
viru
particl
harvest
three
freezethaw
cycl
viru
propag
rd
cell
anim
studi
rd
cell
seed
cm
cultur
dish
incub
incub
overnight
plate
cell
wash
pb
twice
infect
dmem
supplement
fb
h
infect
viru
supernat
ste
suppli
authent
sun
ten
pharmaceut
co
ltd
taipei
taiwan
voucher
specimen
deposit
herbarium
chang
gung
univers
taoyuan
taiwan
five
gram
lyophil
powder
dissolv
ml
distil
water
constant
shake
room
temperatur
period
h
insolubl
substanc
remov
centrifug
g
min
subsequ
centrifug
g
min
aqueou
extract
st
filtrat
filter
drug
dilut
cultur
medium
use
store
titer
viru
determin
plaqu
assay
vero
rd
cell
viral
supernat
serial
dilut
serum
free
medium
tenfold
manner
monolay
cell
confluenc
infect
dilut
viral
supernat
viral
titer
quantifi
form
plaqu
form
unit
pfu
per
ml
previous
plaqu
reduct
assay
cell
sixwel
plate
infect
pfu
viru
h
remov
unabsorb
viru
cell
overlaid
agaros
medium
supplement
serum
differ
concentr
ste
control
group
mock
infect
cell
treat
concentr
ste
plaqu
size
number
determin
assess
antivir
activ
ste
monolay
rd
cell
infect
multipl
infect
serum
free
medium
h
viral
absorpt
dmem
supplement
fb
differ
concentr
ste
ad
infect
cell
total
rna
infect
cell
hour
post
infect
p
extract
use
total
rna
mini
kit
geneaid
sijhih
district
new
taipei
citi
taiwan
accord
manufactur
instruct
rel
copi
number
quantifi
previous
protein
sampl
cell
subject
sdspage
western
blot
analysi
previous
antibodi
use
studi
list
supplementari
tabl
brcr
dilut
pfuml
ml
incub
without
mgml
ste
h
ice
medium
contain
unadsorb
viru
transfer
amicon
ultra
centrifug
filter
unit
membran
merck
millipor
darmstadt
germani
ste
remov
centrifug
g
min
viral
particl
retent
resuspend
ml
serumfre
dmem
titer
viru
quantifi
plaqu
assay
antioxid
power
ste
measur
format
ferrou
tripyridyltriazin
previous
method
base
abil
antioxid
reduc
ferrictripyridyltriazin
complex
ferrou
form
absorpt
maximum
nm
determin
intracellular
ro
format
cell
stain
cellperm
fluorogen
dye
cellrox
deep
red
reagent
previous
method
base
abil
intracellular
ro
oxid
leuco
dye
fluoresc
form
make
dyeladen
cell
amen
cytometr
analysi
bicistron
plasmid
gift
dr
shinru
shih
chang
gang
univers
plasmid
construct
previous
encod
bicistron
mrna
express
renilla
luciferas
rluc
control
cytomegaloviru
cmv
promot
express
firefli
luciferas
fluc
regul
ire
plasmid
dna
transfect
rd
cell
lipofectamin
accord
manufactur
protocol
twelv
hour
transfect
cell
un
infect
pfu
hour
one
hour
later
fb
supplement
indic
final
concentr
ste
ad
well
h
cell
lysat
harvest
enzym
activ
measur
dualluciferas
report
assay
system
promega
madison
usa
glomax
singl
tube
luminomet
promega
madison
usa
accord
manufactur
instruct
plasmid
pgfphnrnp
encod
green
fluoresc
protein
gfp
tag
hnrnp
protein
rd
cell
transfect
pgfphnrnp
plasmid
use
lipofectamin
h
posttransfect
cell
infect
without
pfu
brcr
h
viru
adsorpt
dmem
contain
fb
differ
concentr
ste
ad
infect
cell
incub
anoth
h
infect
mock
treat
cell
fix
formalin
min
cell
nuclei
stain
hoechst
thermo
fisher
scientif
inc
waltham
usa
pb
room
temperatur
imag
fluoresc
assay
obtain
use
cell
analyz
ge
healthcar
life
scienc
usa
region
nucleu
defin
blue
fluoresc
region
transloc
hnrnp
nucleu
cytoplasm
visual
increas
intens
green
fluoresc
cytoplasm
nucleu
percentag
cell
show
hnrnp
reloc
quantifi
random
field
per
well
confoc
microscop
studi
rd
cell
seed
mm
glass
bottom
cultur
dish
coat
polydlysin
mattek
corpor
usa
treat
describ
stain
cell
examin
zeiss
lsm
system
carl
zeiss
microimag
gmbh
heidelberg
germani
previous
specificpathogenfre
sevendayold
icr
mice
laboratori
anim
center
colleg
medicin
nation
cheng
kung
univers
tainan
taiwan
infect
intraperiton
pfu
suspend
dmem
infect
mice
given
singl
dose
water
ste
mgkg
daili
day
intraperiteron
inject
start
form
one
day
infect
infect
mice
observ
daili
day
clinic
symptom
surviv
anim
method
care
describ
present
studi
carri
accord
nation
guid
approv
institut
anim
care
use
committe
nation
cheng
kung
univers
iacuc
result
repres
mean
sd
statist
analys
comput
graphpad
prism
softwar
graphpad
softwar
inc
san
diego
california
usa
two
tail
unpair
student
test
use
compar
mean
valu
two
group
logrank
test
use
compar
surviv
mice
drugtreat
watertr
group
p
valu
less
consid
signific
